Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9653498 | 0.94 | GAA (0.42) | GAARAB9AL3MBTL1KMT2AMEN1 | |
| SCHEMBL7802935 | 0.94 | GAA (0.42) | GAARAB9AL3MBTL1KMT2AMEN1 | |
| SCHEMBL9056134 | 0.94 | ALOX5 (0.43) | GAARAB9AKMT2AMEN1ALOX5 | |
| SCHEMBL463370 | 0.94 | ALOX5 (0.43) | GAARAB9AKMT2AMEN1ALOX5 | |
| SCHEMBL7801906 | 0.92 | RAB9A (0.42) | GAARAB9AL3MBTL1KMT2AMEN1 | |
| SCHEMBL10704838 | 0.90 | RAB9A (0.41) | GAARAB9AL3MBTL1KMT2AMEN1 | |
| SCHEMBL9056157 | 0.88 | RAB9A (0.43) | GAARAB9AKMT2AMEN1ALOX5 | |
| SCHEMBL7801728 | 0.88 | ALOX5 (0.46) | GAARAB9AKMT2AALOX5PIK3CD | |
| SCHEMBL9056711 | 0.88 | ALOX5 (0.46) | GAARAB9AKMT2AALOX5PIK3CD | |
| SCHEMBL11849011 | 0.85 | ALOX5 (0.46) | GAARAB9AL3MBTL1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112165949-A | Topical therapy using taxane nanoparticles for the treatment of Cervical Intraepithelial Neoplasia (CIN) and cervical cancer | DFB索里亚有限责任公司 | 2021-01-01 | — | — | CN | disclosed |